Swiss pharmaceuticals maker Roche Holding AG said yesterday its third-quarter sales rose 14 percent to 12.4 billion Swiss francs (US$12.24 billion) from SF11.3 billion the previous year, driven by strong growth in cancer and flu drugs.
The results, which beat most analyst predictions, prompted the Swiss drugmaker to raise its full-year outlook.
Roche said it now expects at least high single-digit sales growth for its pharmaceuticals division this year while its diagnostics division, too, is “expected to grow well ahead of market” this year.
Roche chief executive Severin Schwan said the integration US biotech firm Genentech was progressing well.
GENENTECH PURCHASE
Roche completed its US$46.8 billion takeover of Genentech in March after a protracted battle to win over Genentech shareholders, many of whom had expressed concern about a clash of corporate cultures between the Swiss and California-based companies.
Sales of Roche says sales of cancer drug Avastin — to treat advanced colorectal, breast, lung and kidney cancer, as well as relapsed glioblastoma, a type of brain tumor — grew 21 percent and reached SF1.59 billion.
Two other cancer drugs, Rituxan — known as MabThera in Europe — and Herceptin, also broke through the SF1 billion sales barrier, grossing SF1.51 billion and SF1.33 billion respectively.
Tamiflu sales increased more than eight-fold to SF994 million, and full-year sales are expected to reach SF2.7 billion, Roche said.
Demand for the drug shot up earlier this year when the WHO declared a swine flu pandemic and said Tamiflu was one of two anti-viral medicines effective against the H1N1 strain.
The other is Relenza, produced by GlaxoSmithKline.
PFIZER
Separately, Pfizer said on Wednesday it was ready to close its deal to buy pharmaceutical rival Wyeth, boosting the size of the world’s biggest drugmaker, after getting US and Canadian regulatory approval.
Pfizer, the maker of Viagra for erectile dysfunction and Lipitor for cholesterol, said it expected to close the transaction yesterday after getting approval from the US Federal Trade Commission and Canadian authorities.
“With the receipt of these clearances, Pfizer has now satisfied the regulatory approval requirements under the merger agreement to complete the acquisition of Wyeth,” the company said.
Regulators had required Pfizer to sell certain animal health assets in the US and Canada to Boehringer Ingelheim, as previously announced.
Pfizer, already the world’s biggest pharmaceutical firm, announced the planned merger in January, seeking diversification as it prepares for the expiration of patents on its blockbuster drugs.
The EU’s executive branch — which enforces EU competition law — approved the deal earlier this year, also contingent on Pfizer’s commitment to divest some of its operations in animal health vaccines, pharmaceuticals and medicinal feed additives in Europe.
NO-LIMITS PARTNERSHIP: ‘The bottom line’ is that if the US were to have a conflict with China or Russia it would likely open up a second front with the other, a US senator said Beijing and Moscow could cooperate in a conflict over Taiwan, the top US intelligence chief told the US Senate this week. “We see China and Russia, for the first time, exercising together in relation to Taiwan and recognizing that this is a place where China definitely wants Russia to be working with them, and we see no reason why they wouldn’t,” US Director of National Intelligence Avril Haines told a US Senate Committee on Armed Services hearing on Thursday. US Senator Mike Rounds asked Haines about such a potential scenario. He also asked US Defense Intelligence Agency Director Lieutenant General Jeffrey Kruse
INSPIRING: Taiwan has been a model in the Asia-Pacific region with its democratic transition, free and fair elections and open society, the vice president-elect said Taiwan can play a leadership role in the Asia-Pacific region, vice president-elect Hsiao Bi-khim (蕭美琴) told a forum in Taipei yesterday, highlighting the nation’s resilience in the face of geopolitical challenges. “Not only can Taiwan help, but Taiwan can lead ... not only can Taiwan play a leadership role, but Taiwan’s leadership is important to the world,” Hsiao told the annual forum hosted by the Center for Asia-Pacific Resilience and Innovation think tank. Hsiao thanked Taiwan’s international friends for their long-term support, citing the example of US President Joe Biden last month signing into law a bill to provide aid to Taiwan,
China’s intrusive and territorial claims in the Indo-Pacific region are “illegal, coercive, aggressive and deceptive,” new US Indo-Pacific Commander Admiral Samuel Paparo said on Friday, adding that he would continue working with allies and partners to keep the area free and open. Paparo made the remarks at a change-of-command ceremony at Joint Base Pearl Harbor-Hickam in Hawaii, where he took over the command from Admiral John Aquilino. “Our world faces a complex problem set in the troubling actions of the People’s Republic of China [PRC] and its rapid buildup of forces. We must be ready to answer the PRC’s increasingly intrusive and
STATE OF THE NATION: The legislature should invite the president to deliver an address every year, the TPP said, adding that Lai should also have to answer legislators’ questions The Chinese Nationalist Party (KMT) yesterday proposed inviting president-elect William Lai (賴清德) to make a historic first state of the nation address at the legislature following his inauguration on May 20. Lai is expected to face many domestic and international challenges, and should clarify his intended policies with the public’s representatives, KMT caucus secretary-general Hung Meng-kai (洪孟楷) said when making the proposal at a meeting of the legislature’s Procedure Committee. The committee voted to add the item to the agenda for Friday, along with another similar proposal put forward by the Taiwan People’s Party (TPP). The invitation is in line with Article 15-2